跳至主要内容
临床试验/NCT01959009
NCT01959009Unknown不适用

Does High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths Improve Oxygenation Compared to High Frequency Oscillatory Ventilation Without Sigh Breaths in Neonates?

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2014年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
16
试验地点
1
主要终点
Delta-a/A-ratio

研究概览

简要总结

Background:

Ventilator induced lung injury (VILI) remains a problem in neonatology. High frequency oscillatory ventilation (HFOV) provides effective gas exchange with minimal pressure fluctuation around a continuous distending pressure and therefore small tidal volume. Animal studies showed that recruitment and maintenance of functional residual capacity (FRC) during HFOV ("open lung concept") could reduce lung injury.

"Open lung HFOV" is achieved by delivering a moderate high mean airway pressure (MAP) using oxygenation as a guide of lung recruitment. Some neonatologists suggest combining HFOV with recurrent sigh-breaths (HFOV-sigh) delivered as modified conventional ventilator-breaths at a rate of 3/min. The clinical observation is that HFOV-sigh leads to more stable oxygenation, quicker weaning and shorter ventilation. This may be related to improved lung recruitment. This has however to our knowledge not been tested in a clinical trial using modern ventilators.

Purpose, aims:

  • To compare HFOV-sigh with HFOV-only and determine if there is a difference in oxygenation expressed as a/A-ratio and/or stability of oxygenation expressed as percentage time with oxygen saturation outside the reference range.
  • To provide information on feasibility and treatment effect of HFOV-sigh to assist planning larger studies. We hypothesize that oxygenation is better during HFOV-sigh.

Methods:

Infants at 24-36 weeks corrected gestational age already on HFOV are eligible. Patients will be randomly assigned to HFOV-sigh (3 breaths/min) followed by HFOV-only or vice versa for 4 alternating 1-hours periods (2-treatment, double crossover design, each patient being its own control). During HFOV-sigh set-pressure will be reduced to keep MAP constant, otherwise HFOV will remain at pretrial settings. Outcome will be calculated from normal clinical parameters including pulx-oximetry and transcutaneous monitoring of oxygen and carbon-dioxide partial pressures.

详细描述

High frequency oscillatory ventilation (HFOV) has been used in neonatal respiratory care for more than three decades. HFOV provides effective gas exchange with minimal pressure fluctuation around a set mean airway pressure (MAP) functioning as a continuous distending pressure (CDP), and low tidal volume compared to conventional ventilation (CV). HFOV was therefore thought to be able to reduce the risk of bronchopulmonary dysplasia in ventilated preterm babies. However results from randomized controlled trials comparing HFOV with conventional ventilation have been conflicting and meta-analyses have not shown clear evidence that HFOV is safer or more effective than conventional ventilation neither when used as initial strategy nor as rescue strategy in preterm babies with respiratory distress syndrome (RDS). Consequently there are no absolute indications for HFOV in preterm babies and most neonatologists today use HFOV as a rescue mode when conventional ventilation is failing in the acute setting of RDS as well as in the baby with bronchopulmonary dysplasia.

Maintaining adequate functional residual capacity (FRC) together with the fraction of inspired oxygen FiO2 are the main determinants of oxygenation. The larger the FRC, the larger is the volume of available oxygen in the alveoli for gas transport. Adequate oxygen saturation (SAT) of the blood in room air or an improvement in oxygen-saturation without changing the fraction of inspired oxygen can be seen as an indirect indicator of normal or normalized FRC, and most neonatologists use oxygenation as an indirect marker for lung volume during HFOV.

The CDP or set-MAP is the main determinant of lung-aeration during HFOV. A too low MAP may cause non-homogenous aeration and atelectasis leading to atelectotrauma and redirection of airflow to more compliant alveoli leading to localized hyperinflation.

Accordingly, early animal studies showed that recruitment and maintenance of FRC during HFOV could reduce lung injury. Lung recruitment was initially achieved by superimposing conventional ventilation (CV) breaths on top of HFOV with lower MAP than used today, either as recurrent sustained inflations lasting 15-20 seconds about every 20 minute, as intermittent sigh breaths (3-5 tidal breaths pr minute) delivered as normal conventional breaths or as conventional ventilation at normal rate combined with HFOV.

Today most neonatologists perform this so-called "open lung" concept by adjusting the set-MAP using oxygenation as an indirect guide of lung recruitment. Different approaches are used explained by difficulties in direct bedside monitoring of FRC. Some initiate HFOV with MAP 2-3 cm H2O above the MAP needed during conventional ventilation subsequently adjusting MAP until the fraction of inspired O2 (FiO2) <0.25-0.6 providing no signs of over inflation of the lungs on x-ray. Others go through a more complex step-wise increase in MAP till FiO2 cannot be reduced further, and then gradually decrease MAP until FiO2 again needs to be increased to maintain a predefined SAT and then continues ventilations with a MAP set at 2 cm H2O above this point, thereby placing ventilation on the more compliant deflation limb of the pressure-volume relationship of the lung.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
24 Weeks 至 44 Weeks(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Infants at 24-36 weeks corrected gestational age
  • •Already ventilated with high frequency ventilation
  • •Requiring FiO2=21%-70% to maintain adequate oxygen saturation.
  • •Clinical stable
  • •o i.e. ventilated on current settings for more than just a few hours with stable but not necessarily normalized blood gases or transcutaneous values and oxygen requirement.
  • •Parent(s) or guardian able and willing to provide informed consent

排除标准

  • •Major congenital cardiovascular or respiratory abnormalities.
  • •The attending neonatologist responsible for the baby considers one of the ventilation modes unsuitable for the infant.
  • •Poor skin integrity precluding use of transcutaneous monitoring.
  • •Lack of parental signed written informed consent.
  • •Parents under 18 years of age.

研究组 & 干预措施

HFOV-sigh at start

Experimental

Each patient will be exposed to either HFOV alone (HFOV-only) or HFOV combined with sigh breaths (HFOV-sigh), but in different order.

MAP=mean airway pressure.

DURING HFOV-SIGH:

  • Frequency 3 breaths/min
  • Ti = 1s
  • Peak inspiratory pressure (PIP) = 30 cm H2O

For patients already on HFOV-sigh at study start:

• MAP-set will be left unchanged at pre-trial settings.

For patients on HFOV-only at study start:

• During periods with superimposed sigh breaths, MAP-set will be reduced in accordance with a calculation of MAP aiming to keep average mean airway-pressure (MAP) unchanged. (MAP=(PIP*Tinsp+PEEP*Texp)/(Tinsp+Texp)

DURING HFOV-ONLY

For patients on HFOV-sigh at study start:

• During HFOV-only, the MAP-set will be increased in accordance with a calculation of MAP, aiming to keep average mean airway-pressure (MAP) unchanged.

For patients on HFOV-only at study start:

• MAP-set will be left unchanged at pre-trial settings.

干预措施: HFOV combined with sigh breaths (Other)

HFOV-only at start

Experimental

Each patient will be exposed to either HFOV alone (HFOV-only) or HFOV combined with sigh breaths (HFOV-sigh), but in different order.

MAP=mean airway pressure.

DURING HFOV-SIGH:

  • Frequency 3 breaths/min
  • Ti = 1s
  • Peak inspiratory pressure (PIP) = 30 cm H2O

For patients already on HFOV-sigh at study start:

• MAP-set will be left unchanged at pre-trial settings.

For patients on HFOV-only at study start:

• During periods with superimposed sigh breaths, MAP-set will be reduced in accordance with a calculation of MAP aiming to keep average mean airway-pressure (MAP) unchanged. (MAP=(PIP*Tinsp+PEEP*Texp)/(Tinsp+Texp)

DURING HFOV-ONLY

For patients on HFOV-sigh at study start:

• During HFOV-only, the MAP-set will be increased in accordance with a calculation of MAP, aiming to keep average mean airway-pressure (MAP) unchanged.

For patients on HFOV-only at study start:

• MAP-set will be left unchanged at pre-trial settings.

干预措施: HFOV combined with sigh breaths (Other)

结局指标

主要结局

Delta-a/A-ratio

时间窗: on study day

a/A-ratio calculated as a/A-ratio= TcPO2/(0,95\*FiO2- TcPCO2) By delta-a/A-ratio means the difference in a/A-ratio between the two modes of ventilation, as an indirect measure of lung recruitment.

stability of oxygen saturation

时间窗: on study day

The difference in area-under-the-curve for "out of range" for oxygen saturation (based on accepted general reference ranges for the given gestational age).

次要结局

  • Partial pressure of CO2(on study day)
  • heart rate(on study date)
  • FiO2(on study day)
  • Partial pressure of O2(on study date)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christian Heiring

Neonatologist

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验